# Effect on Bleeding When Using FloSeal Matrix™ in Subjects Undergoing Endoscopic Vein Harvest (EVH)

> **NCT00742313** · PHASE4 · TERMINATED · sponsor: **Duke University** · enrollment: 50 (actual)

## Conditions studied

- Bleeding

## Interventions

- **BIOLOGICAL:** FloSeal Matrix

## Key facts

- **NCT ID:** NCT00742313
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** No statistical differences on study endpoints between groups.
- **Last updated:** 2014-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00742313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00742313, "Effect on Bleeding When Using FloSeal Matrix™ in Subjects Undergoing Endoscopic Vein Harvest (EVH)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00742313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
